株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

感染免疫学:世界のパイプライン分析・競合情勢・市場予測(〜2018年)

Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

発行 GlobalData 商品コード 244968
出版日 ページ情報 英文 105 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
感染免疫学:世界のパイプライン分析・競合情勢・市場予測(〜2018年) Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
出版日: 2012年06月18日 ページ情報: 英文 105 Pages
概要

当レポートでは、世界の感染免疫学市場について分析し、市場情勢、競合情勢、および市場動向情報を提供しており、セグメントおよび国別の収益データ実績と予測、2011年における企業の市場シェア、市場動向・市場促進因子・市場阻害因子の定性分析、主なパイプライン製品と技術の分析、および主要企業のプロファイルを含め、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 感染免疫学の概要

  • 感染免疫学:市場特徴

第4章 感染免疫学:世界市場の特徴

  • 世界市場の収益実績:2004年〜2011年
  • 世界市場の収益実績予測:2011年〜2018年
  • 主要動向
  • 市場力学

第5章 感染免疫学市場:セグメント別の分析

  • 世界の細菌学市場の収益実績:2004年〜2011年
  • 世界の細菌学市場の収益実績予測:2011年〜2018年
  • 細菌学市場の力学
  • 世界の肝炎ウィルス診断市場の収益実績:2004年〜2011年
  • 世界の肝炎ウィルス診断市場の収益実績予測:2011年〜2018年
  • 肝炎ウィルス診断市場の力学
  • 世界のその他のウィルス学市場の収益実績:2004年〜2011年
  • 世界のその他のウィルス市場の収益実績予測:2011年〜2018年
  • その他のウィルス市場の力学
  • 世界のレトロウィルス市場の収益実績:2004年〜2011年
  • 世界のレトロウィルス市場の収益実績予測:2011年〜2018年
  • レトロウィルス市場の力学

第6章 感染免疫学市場:国別の収益分析(2004年〜2018年)

  • 米国市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)
  • カナダ市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)
  • 英国市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)
  • ドイツ市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)
  • フランス市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)
  • イタリア市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)
  • スペイン市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)
  • 日本市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)
  • 中国市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)
  • インド市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)
  • オーストラリア市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)
  • ブラジル市場における収益実績(2004年〜2011年)・予測(2011年〜2018年)

第7章 感染免疫学市場:戦略的競合力評価

  • 感染免疫学の市場シェア評価
  • 主な市場参入企業

第8章 感染免疫学:戦略的パイプライン評価

第9章 感染免疫学市場:戦略的契約分析

  • 提携:2010年〜2012年
  • ベンチャー資金調達契約:2010年〜2012年
  • 資産取引契約:2010年〜2012年
  • 株式売出契約:2010年〜2012年
  • 買収:2010年〜2012年
  • 債権の新規発行契約:2010年〜2012年
  • 未公開株式(PE)契約:2010年〜2012年
  • 合併:2010年〜2012年
  • ライセンシング合意:2010年〜2012年
  • 主要契約

第10章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0150MAR

Summary

GlobalData's new report, "Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global infectious immunology market. The report provides market landscape, competitive landscape and market trends information on the infectious immunology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Brazil and Australia.
  • Key segments covered include Hepatitis Viruses, Retroviruses, Bacteriology and Other Virology.
  • Annualized market revenues data from 2004 to 2011 and forecast forward for seven years to 2018. Company shares data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints within infectious immunology market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Qiagen and Gen-Probe Incorporated.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the infectious immunology market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What's the next big thing in the infectious immunology market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global infectious immunology market and the factors shaping it.

Table of contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Infectious Immunology Overview

  • 3.1. Infectious Immunology: Market Characterization
    • 3.1.1. Bacteriology
    • 3.1.2. Hepatitis Viruses
    • 3.1.3. Other Virology
    • 3.1.4. Retroviruses

4. Infectious Immunology-Global Market Characterization

  • 4.1. Infectious Immunology Market, Global, Revenue ($m), Historic, 2004-2011
  • 4.2. Infectious Immunology Market, Global, Revenue ($m), Forecast, 2011-2018
  • 4.3. Infectious Immunology Market, Key Trends
    • 4.3.1. New Technological Developments to Change the Infectious Immunology Market Landscape
    • 4.3.2. Use of Companion Diagnostics to Provide a Personalized Healthcare Solution for Infectious Disease Treatment can be a Key Focus Area in Future
    • 4.3.3. Growing Trend of Development of POCT Tests for Infectious Immunology due to Benefits such as Low Cost and Faster Results
  • 4.4. Global Infectious Immunology, Market Dynamics
    • 4.4.1. Market Drivers
    • 4.4.2. Market Restraints

5. Global Infectious Immunology Market: Analysis by Segment

  • 5.1. Bacteriology Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.2. Bacteriology Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.3. Bacteriology, Market Dynamics
    • 5.3.1. Market Drivers
    • 5.3.2. Market Restraint
  • 5.4. Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.5. Hepatitis viruses diagnostics Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.6. Hepatitis Viruses Diagnostics, Market Dynamics
    • 5.6.1. Market Drivers
    • 5.6.2. Market Restraint
  • 5.7. Other Virology Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.8. Other Virology Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.9. Other Virology, Market Dynamics
    • 5.9.1. Market Drivers
    • 5.9.2. Market Restraint
  • 5.10. Retroviruses Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.11. Retroviruses Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.12. Retroviruses, Market Dynamics
    • 5.12.1. Market Driver
    • 5.12.2. Market Restraint

6. Infectious Immunology Market, Analysis by Country, Revenue ($m), 2004-2018

  • 6.1. Infectious Immunology Market, the US, Revenue ($m), Historic, 2004-2011
  • 6.2. Infectious Immunology Market, the US, Revenue ($m), Forecast, 2011-2018
  • 6.3. Infectious Immunology Market, Canada, Revenue ($m), Historic, 2004. -2011
  • 6.4. Infectious Immunology Market, Canada, Revenue ($m), Forecast, 2011-2018
  • 6.5. Infectious Immunology Market, the UK, Revenue ($m), Historic, 2004-2011
  • 6.6. Infectious Immunology Market, the UK, Revenue ($m), Forecast, 2011-2018
  • 6.7. Infectious Immunology Market, Germany, Revenue ($m), Historic, 2004-2011
  • 6.8. Infectious Immunology Market, Germany, Revenue ($m), Forecast, 2011-2018
  • 6.9. Infectious Immunology Market, France, Revenue ($m), Historic, 2004-2011
  • 6.10. Infectious Immunology Market, France, Revenue ($m), Forecast, 2011-2018
  • 6.11. Infectious Immunology Market, Italy, Revenue ($m), Historic, 2004-2011
  • 6.12. Infectious Immunology Market, Italy, Revenue ($m), Forecast, 2011-2018
  • 6.13. Infectious Immunology Market, Spain, Revenue ($m), Historic, 2004-2011
  • 6.14. Infectious Immunology Market, Spain, Revenue ($m), Forecast, 2011-2018
  • 6.15. Infectious Immunology Market, Japan, Revenue ($m), Historic, 2004-2011
  • 6.16. Infectious Immunology Market, Japan, Revenue ($m), Forecast, 2011-2018
  • 6.17. Infectious Immunology Market, China, Revenue ($m), Historic, 2004-2011
  • 6.18. Infectious Immunology Market, China, Revenue ($m), Forecast, 2011-2018
  • 6.19. Infectious Immunology Market, India, Revenue ($m), Historic, 2004-2011
  • 6.20. Infectious Immunology Market, India, Revenue ($m), Forecast, 2011-2018
  • 6.21. Infectious Immunology Market, Australia, Revenue ($m), Historic, 2004-2011
  • 6.22. Infectious Immunology Market, Australia, Revenue ($m), Forecast, 2011-2018
  • 6.23. Infectious Immunology Market, Brazil, Revenue ($m), Historic, 2004-2011
  • 6.24. Infectious Immunology Market, Brazil, Revenue ($m), Forecast, 2011-2018

7. Infectious Immunology Market-Strategic Competitive Assessment

  • 7.1. Infectious Immunology, Market Share Assessment for Others
  • 7.2. Infectious Immunology, Key Market Participants
    • 7.2.1. Abbott Laboratories
    • 7.2.2. F. Hoffmann-La Roche Ltd.
    • 7.2.3. Siemens Healthcare

8. Infectious Immunology-Strategic Pipeline Assessment

9. Infectious Immunology Market-Strategic Deals Analysis

  • 9.1. Infectious Immunology Market, Partnerships, 2010-2012*
  • 9.2. Infectious Immunology Market, Venture Financing Deals, 2010-2012*
  • 9.3. Infectious Immunology Market, Asset Transaction Deals, 2010-2012*
  • 9.4. Infectious Immunology Market, Equity Offering Deals, 2010-2012*
  • 9.5. Infectious Immunology Market, Acquisitions, 2010-2012*
  • 9.6. Infectious Immunology Market, Debt Offering Deals, 2010-2012*
  • 9.7. Infectious Immunology Market, Private Equity Deals, 2010-2012*
  • 9.8. Infectious Immunology Market, Mergers, 2010-2012*
  • 9.9. Infectious Immunology Market, Licensing Agreement, 2010-2012*
  • 9.10. Key Deals
    • 9.10.1. Siemens Healthcare Diagnostics and Illumina Entered into a Collaboration Partnership
    • 9.10.2. Xcyton Announces Receipt of $4.5m from Fidelity Capital Advisors to Launch Novel Diagnostic Platform 'SES' for Critical Infections
    • 9.10.3. Abbott Enters into Co-Development Agreement with Genetics Lab for Molecular Assay Development
    • 9.10.4. Quanterix, Beth Israel Deaconess and Forsyth Institute Enter into Partnership to Develop a Tuberculosis Test

10. Appendix

  • 10.1. Market Definitions
    • 10.1.1. Infectious Immunology
  • 10.2. Acronyms
  • 10.3. Sources
  • 10.4. Research Methodology
    • 10.4.1. Secondary Research
    • 10.4.2. Primary Research
    • 10.4.3. Models
    • 10.4.4. Forecasts
    • 10.4.5. Expert Panels
  • 10.5. GlobalData Consulting
  • 10.6. Contact Us
  • 10.7. Disclaimer

List of Tables

  • Table 1: List of Viruses which Commonly Infect Humans, by Nucleic Acid and Family*
  • Table 2: Infectious Immunology Market, Global, Revenue ($m), 2004 - 2011
  • Table 3: Infectious Immunology Market, Global, Revenue ($m), 2011 - 2018
  • Table 4: Home Based Testing Market, by Application and Test Type
  • Table 5: Number of Corporate Diagnostic Laboratory Chains, India, 2010
  • Table 6: Bacteriology Market, Global, Revenue ($m), 2004 - 2011
  • Table 7: Bacteriology Market, Global, Revenue ($m), 2011 - 2018
  • Table 8: Bacteriology Market CAGR Comparison, by Country, 2004-2011
  • Table 9: Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), 2004 - 2011
  • Table 10: Hepatitis viruses diagnostics Market, Global, Revenue ($m), 2011 - 2018
  • Table 11: Other Virology Market, Global, Revenue ($m), 2004 - 2011
  • Table 12: Other Virology Market, Global, Revenue ($m), 2011 - 2018
  • Table 13: Retroviruses Market, Global, Revenue ($m), 2004 - 2011
  • Table 14: Retroviruses Market, Global, Revenue ($m), 2011 - 2018
  • Table 15: Number of New HIV Infection Cases, the US, 2006-2009
  • Table 16: Infectious Immunology Market, the US, Revenue ($m), 2004 - 2011
  • Table 17: Infectious Immunology Market, the US, Revenue ($m), 2011 - 2018
  • Table 18: Infectious Immunology Market, Canada, Revenue ($m), 2004-2011
  • Table 19: Infectious Immunology Market, Canada, Revenue ($m), 2011 - 2018
  • Table 20: Infectious Immunology Market, the UK, Revenue ($m), 2004-2011
  • Table 21: Infectious Immunology Market, the UK, Revenue ($m), 2011 - 2018
  • Table 22: Infectious Immunology Market, Germany, Revenue ($m), 2004 - 2011
  • Table 23: Infectious Immunology Market, Germany, Revenue ($m), 2011-2018
  • Table 24: Infectious Immunology Market, France, Revenue ($m), 2004-2011
  • Table 25: Infectious Immunology Market, France, Revenue ($m), 2011-2018
  • Table 26: Infectious Immunology Market, Italy, Revenue ($m), 2004-2011
  • Table 27: Infectious Immunology Market, Italy, Revenue ($m), 2011-2018
  • Table 28: Infectious Immunology Market, Spain, Revenue ($), 2004-2011
  • Table 29: Infectious Immunology Market, Spain, Revenue ($m), 2011-2018
  • Table 30: Infectious Immunology Market, Japan, Revenue ($m), 2004-2011
  • Table 31: Infectious Immunology Market, Japan, Revenue ($m), 2011-2018
  • Table 32: Infectious Immunology Market, China, Revenue ($m), 2004-2011
  • Table 33: Infectious Immunology Market, China, Revenue ($m), 2011-2018
  • Table 34: Infectious Immunology Market, India, Revenue ($m), 2004-2011
  • Table 35: Infectious Immunology Market, India, Revenue ($m), 2011-2018
  • Table 36: Infectious Immunology Market, Australia, Revenue ($m), 2004-2011
  • Table 37: Infectious Immunology Market, Australia, Revenue ($m), 2011-2018
  • Table 38: Infectious Immunology Market, Brazil, Revenue ($m), 2004-2011
  • Table 39: Infectious Immunology Market, Brazil, Revenue ($m), 2011-2018
  • Table 40: Infectious Immunology Market, Global, Company Share (%), 2011
  • Table 41: Abbott Laboratories, Key Marketed Products*, 2011
  • Table 42: F. Hoffmann-La Roche Ltd., Key Marketed Products*, 2011
  • Table 43: Roche, Infectious Disease Companion Diagnostics Tests, 2011
  • Table 44: Siemens Healthcare, Key Marketed Products*, 2011
  • Table 45: Siemens Healthcare, Emerging Markets Growth, 2008-2010
  • Table 46: Infectious Immunology, Global Pipeline Products, 2011
  • Table 47: Infectious Immunology, Global Pipeline Distribution, by Market Segments, 2011
  • Table 48: Infectious Immunology Market, Deals, 2010-2012*
  • Table 49: Infectious Immunology Market, Partnerships, 2010-2012*
  • Table 50: Infectious Immunology Market, Venture Financing Deals, 2010-2012*
  • Table 51: Infectious Immunology Market, Asset Transaction Deals, 2010-2012*
  • Table 52: Infectious Immunology Market, Equity Offering Deals, 2010-2012*
  • Table 53: Infectious Immunology Market, Acquisitions, 2010-2012*
  • Table 54: Infectious Immunology Market, Debt Offering Deals, 2010-2012*
  • Table 55: Infectious Immunology Market, Private Equity Deals, 2010-2012*
  • Table 56: Infectious Immunology Market, Mergers, 2010-2012*
  • Table 57: Infectious Immunology Market, Licensing Agreement, 2010-2012*

List of Figures

  • Figure 1: Infectious Immunology, Market Segmentation
  • Figure 2: Infectious Immunology Market, Global, Revenue ($m), 2004 - 2011
  • Figure 3: Infectious Immunology Market, Global, Revenue ($m), 2011 - 2018
  • Figure 4: Global Infectious Immunology, Market Dynamics
  • Figure 5: Hub and Spoke Model used by Diagnostic Laboratories
  • Figure 6: Innovation Funnel, Biomarker-based Molecular Diagnostic Product
  • Figure 7: Bacteriology Market, Global, Revenue ($m), 2004 - 2011
  • Figure 8: Bacteriology Market, Global, Revenue ($m), 2011 - 2018
  • Figure 9: Bacteriology Market CAGR Comparison, by Country, 2004-2011
  • Figure 10: Bacteriology Market, Developed* vs. Developing** Countries, Revenue Contribution (%)
  • Figure 11: Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), 2004 - 2011
  • Figure 12: Hepatitis viruses diagnostics Market, Global, Revenue ($m), 2011 - 2018
  • Figure 13: Hepatitis Testing Market Comparison, Developed* vs. Developing** Markets, 2011
  • Figure 14: Estimated New Cases for Hepatitis, the US, 2004-2009
  • Figure 15: Other Virology Market, Global, Revenue ($m), 2004 - 2011
  • Figure 16: Other Virology Market, Global, Revenue ($m), 2011 - 2018
  • Figure 17: Retroviruses Market, Global, Revenue ($m), 2004 - 2011
  • Figure 18: Retroviruses Market, Global, Revenue ($m), 2011 - 2018
  • Figure 19: Number of New HIV Infection Cases, the US, 2006-2009
  • Figure 20: Infectious Immunology Market, the US, Revenue ($m), 2004 - 2011
  • Figure 21: Infectious Immunology Market, the US, Revenue ($m), 2011 - 2018
  • Figure 22: Infectious Immunology Market, Canada, Revenue ($m), 2004 - 2011
  • Figure 23: Infectious Immunology Market, Canada, Revenue ($m), 2011 - 2018
  • Figure 24: Infectious Immunology Market, the UK, Revenue ($m), 2004 - 2011
  • Figure 25: Infectious Immunology Market, the UK, Revenue ($m), 2011 - 2018
  • Figure 26: Infectious Immunology Market, Germany, Revenue ($m), 2004 - 2011
  • Figure 27: Infectious Immunology Market, Germany, Revenue ($m), 2011-2018
  • Figure 28: Infectious Immunology Market, France, Revenue ($m), 2004-2011
  • Figure 29: Infectious Immunology Market, France, Revenue ($m), 2011-2018
  • Figure 30: Infectious Immunology Market, Italy, Revenue ($m), 2004-2011
  • Figure 31: Infectious Immunology Market, Italy, Revenue ($m), 2011-2018
  • Figure 32: Infectious Immunology Market, Spain, Revenue ($m), 2004-2011
  • Figure 33: Infectious Immunology Market, Spain, Revenue ($m), 2011-2018
  • Figure 34: Infectious Immunology Market, Japan, Revenue ($m), 2004-2011
  • Figure 35: Infectious Immunology Market, Japan, Revenue ($m), 2011-2018
  • Figure 36: Infectious Immunology Market, China, Revenue ($m), 2004-2011
  • Figure 37: Infectious Immunology Market, China, Revenue ($m), 2011-2018
  • Figure 38: Infectious Immunology Market, India, Revenue ($m), 2004-2011
  • Figure 39: Infectious Immunology Market, India, Revenue ($m), 2011-2018
  • Figure 40: Infectious Immunology Market, Australia, Revenue ($m), 2004-2011
  • Figure 41: Infectious Immunology Market, Australia, Revenue ($m), 2011-2018
  • Figure 42: Infectious Immunology Market, Brazil, Revenue ($m), 2004-2011
  • Figure 43: Infectious Immunology Market, Brazil, Revenue ($m), 2011-2018
  • Figure 44: Infectious Immunology Market, Global, Company Shares (%), 2011
  • Figure 45: Infectious Immunology, Market Share Assessment for Others
  • Figure 46: Abbott Laboratories, SWOT Analysis
  • Figure 47: F. Hoffmann-La Roche Ltd., SWOT Analysis
  • Figure 48: Roche, Revenue Distribution by Geography, 2011
  • Figure 49: Siemens Healthcare, SWOT Analysis
  • Figure 50: Siemens Healthcare, Revenue Share, by Region, 2010
  • Figure 51: Siemens Healthcare, Emerging Markets Growth, 2008-2010
  • Figure 52: Infectious Immunology, Global Pipeline Products, 2011
  • Figure 53: Infectious Immunology, Global Pipeline Distribution, by Market Segment, 2011
  • Figure 54: Infectious Immunology Market, Deals, 2010-2012*
Back to Top